Shire is looking for FDA approval of a new chewable tablet of its popular ADHD drug Vyvanse that is targeted to children and adolescents.

Highland Therapeutics, a Toronto-based company with delayed-release technology for ADHD treatment, said data from the first of two Phase III trials for its…

Ease of administration is one of the main advantages of UCB's just FDA-approved epilepsy med Briviact. It can be initially delivered without titration,…

Several drug delivery devices are on a draft list of med tech that will be subject to a final guidance calling for the application of human factors and…

The FDA approved a nonalcoholic formulation of docetaxel, freeing cancer patients from the risk of intoxication after treatment with the intravenously…

Computational drug delivery specialist Qrono has just been awarded a $612,000 FDA contract to design and deploy physiologically based pharmacokinetic models of…

Impax Pharma announced that the European Commission has approved its modified-release combination of carbidopa and levodopa to treat Parkinson's disease,…

Adapt Pharma's Narcan nasal spray became the first noninjectable treatment for opioid overdose emergencies thanks to its FDA approval on Nov. 19.